81 related articles for article (PubMed ID: 3804368)
1. A biological approach to optimize interferon treatment in hairy cell leukemia.
Gastl G; Aulitzky W; Tilg H; Nachbaur K; Troppmair J; Flener R; Huber C
Immunobiology; 1986 Sep; 172(3-5):262-8. PubMed ID: 3804368
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
[TBL] [Abstract][Full Text] [Related]
3. [Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon].
Aulitzky W; Gastl G; Troppmair J; Tilg H; Abbrederis K; Nerl C; Flener R; Rokos H; Huber C
Acta Med Austriaca; 1985; 12(5):115-21. PubMed ID: 3832745
[TBL] [Abstract][Full Text] [Related]
4. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
[TBL] [Abstract][Full Text] [Related]
5. [Interferon-alpha in the treatment of hematologic neoplasms].
Aulitzky W; Gastl G; Tilg H; Troppmair J; Leiter E; Geissler D; Flener R; Huber C
Wien Med Wochenschr; 1986 Apr; 136(7-8):172-81. PubMed ID: 3524022
[TBL] [Abstract][Full Text] [Related]
6. The importance of patient monitoring in clinical cytokine trials: use of serum markers to define biologically active doses.
Huber C; Herold M
Cancer Surv; 1989; 8(4):809-15. PubMed ID: 2518331
[TBL] [Abstract][Full Text] [Related]
7. IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients.
Liberati AM; Schippa M; Portuesi MG; Grazia Proietti M; De Angelis V; Ferrajoli A; Cinieri S; Di Clemente F; Palmisano L; Berruto P
Haematologica; 1991; 76(5):375-82. PubMed ID: 1806440
[TBL] [Abstract][Full Text] [Related]
8. Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodies.
Steis RG; Smith JW; Urba WJ; Clark JW; Itri LM; Evans LM; Schoenberger C; Longo DL
N Engl J Med; 1988 Jun; 318(22):1409-13. PubMed ID: 3367950
[TBL] [Abstract][Full Text] [Related]
9. The UCLA experience with type I interferons in hairy cell leukemia.
Glaspy JA; Jacobs AD; Golde DW
Leukemia; 1987 Apr; 1(4):323-6. PubMed ID: 3312839
[TBL] [Abstract][Full Text] [Related]
10. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
Thompson JA; Brady J; Kidd P; Fefer A
Cancer Treat Rep; 1985; 69(7-8):791-3. PubMed ID: 4016788
[TBL] [Abstract][Full Text] [Related]
11. [Use of alpha-interferon in the treatment of patients with hairy cell leukemia].
Gotić M; Rolović Z; Vuković S; Elezović I; Tomić D
Srp Arh Celok Lek; 1990; 118(7-8):277-84. PubMed ID: 2097776
[TBL] [Abstract][Full Text] [Related]
12. The U.K. experience with human lymphoblastoid interferon in HCL: a report of the first 50 cases.
Worman CP; Catovsky D; Cawley JC; Bevan PC; Bottomley JM; Nethersell AB
Leukemia; 1987 Apr; 1(4):320-2. PubMed ID: 3669754
[TBL] [Abstract][Full Text] [Related]
13. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia.
Moormeier JA; Ratain MJ; Westbrook CA; Vardiman JW; Daly KM; Golomb HM
J Natl Cancer Inst; 1989 Aug; 81(15):1172-4. PubMed ID: 2746669
[TBL] [Abstract][Full Text] [Related]
14. Alpha interferon for induction of remission in hairy-cell leukemia.
Quesada JR; Reuben J; Manning JT; Hersh EM; Gutterman JU
N Engl J Med; 1984 Jan; 310(1):15-8. PubMed ID: 6689734
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hairy cell leukemia with increasing doses of recombinant alpha A interferon.
Holmes R; Schwarz MA; Whiteside MG; Firkin FC
Aust N Z J Med; 1988 Jun; 18(4):557-62. PubMed ID: 3196242
[TBL] [Abstract][Full Text] [Related]
16. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
[TBL] [Abstract][Full Text] [Related]
17. In vitro induction of proteins by alpha-interferon in hairy cell leukemia.
Samuels BL; Golomb HM; Brownstein BH
Cancer Res; 1986 Aug; 46(8):4151-5. PubMed ID: 3731082
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hairy cell leukaemia with recombinant alpha interferon.
Romeril KR; Carter JM; Green GJ; Beard ME; Heaton DC; Newhook CH; Gibbons SS; Reddy J
N Z Med J; 1989 Apr; 102(866):186-8. PubMed ID: 2652008
[TBL] [Abstract][Full Text] [Related]
19. Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemia.
Steis RG; Smith JW; Urba WJ; Venzon DJ; Longo DL; Barney R; Evans LM; Itri LM; Ewel CH
Blood; 1991 Feb; 77(4):792-8. PubMed ID: 1704264
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hairy cell leukemia with alpha interferons.
Quesada JR; Gutterman JU; Hersh EM
Cancer; 1986 Apr; 57(8 Suppl):1678-80. PubMed ID: 3948137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]